Unitary SPCs law proposed to complement unitary patents

Pharmaceutical companies will be able to apply for supplementary protection certificates (SPCs) centrally before the European Union Intellectual Property Office (EUIPO) and obtain new unitary SPCs in future to complement new unitary patents granted, under proposals outlined by the European Commission